AllianceBernstein’s Exact Sciences EXAS Stock Holding History

AllianceBernstein’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-823,039	Closed	-$83.6M	–	3255
2025 Q4	$83.6M	Buy	823,039 +747,613	+991%	+$60M	0.03%	460
2025 Q3	$4.13M	Buy	75,426 +2,170	+3%	+$108K	﹤0.01%	1612
2025 Q2	$3.89M	Buy	73,256 +3,845	+6%	+$195K	﹤0.01%	1592
2025 Q1	$3M	Sell	69,411 -434	-0.6%	-$22K	﹤0.01%	1690
2024 Q4	$3.92M	Sell	69,845 -890,747	-93%	-$55.4M	﹤0.01%	1601
2024 Q3	$65.4M	Buy	960,592 +2,223	+0.2%	+$125K	0.02%	536
2024 Q2	$40.5M	Buy	958,369 +878,674	+1,103%	+$48.3M	0.01%	654
2024 Q1	$5.5M	Sell	79,695 -34,897	-30%	-$2.21M	﹤0.01%	1428
2023 Q4	$8.48M	Buy	114,592 +37,698	+49%	+$2.47M	﹤0.01%	1247
2023 Q3	$5.25M	Buy	76,894 +91	+0.1%	+$7.72K	﹤0.01%	1398
2023 Q2	$7.21M	Sell	76,803 -702	-0.9%	-$54.8K	﹤0.01%	1282
2023 Q1	$5.26M	Sell	77,505 -8,370	-10%	-$538K	﹤0.01%	1383
2022 Q4	$4.25M	Buy	85,875 +3,174	+4%	+$130K	﹤0.01%	1507
2022 Q3	$2.69M	Sell	82,701 -351	-0.4%	-$14.5K	﹤0.01%	1696
2022 Q2	$3.27M	Buy	83,052 +5,001	+6%	+$267K	﹤0.01%	1651
2022 Q1	$5.46M	Sell	78,051 -1,447	-2%	-$106K	﹤0.01%	1545
2021 Q4	$6.19M	Sell	79,498 -5,522	-6%	-$487K	﹤0.01%	1507
2021 Q3	$8.12M	Sell	85,020 -1,689	-2%	-$178K	﹤0.01%	1354
2021 Q2	$10.8M	Buy	86,709 +2,322	+3%	+$277K	﹤0.01%	1202
2021 Q1	$11.1M	Sell	84,387 -168	-0.2%	-$23K	﹤0.01%	1151
2020 Q4	$11.2M	Buy	84,555 +1,178	+1%	+$142K	0.01%	1071
2020 Q3	$8.5M	Buy	83,377 +2,370	+3%	+$205K	﹤0.01%	1100
2020 Q2	$7.04M	Buy	81,007 +5,333	+7%	+$426K	﹤0.01%	1154
2020 Q1	$4.39M	Sell	75,674 -15,806	-17%	-$1.28M	﹤0.01%	1249
2019 Q4	$8.46M	Sell	91,480 -317,515	-78%	-$27.9M	﹤0.01%	1152
2019 Q3	$37M	Sell	408,995 -1,076,864	-72%	-$123M	0.02%	602
2019 Q2	$175M	Sell	1,485,859 -335,881	-18%	-$33.8M	0.11%	172
2019 Q1	$158M	Sell	1,821,740 -445,058	-20%	-$37.9M	0.1%	184
2018 Q4	$143M	Sell	2,266,798 -11,425	-0.5%	-$784K	0.11%	187
2018 Q3	$180M	Sell	2,278,223 -207,259	-8%	-$13.5M	0.12%	175
2018 Q2	$149M	Sell	2,485,482 -195,423	-7%	-$10.5M	0.1%	191
2018 Q1	$108M	Buy	2,680,905 +2,442,295	+1,024%	+$119M	0.08%	275
2017 Q4	$12.5M	Buy	238,610 +2,370	+1%	+$127K	0.01%	894
2017 Q3	$11.1M	Hold	236,240	–	–	0.01%	914
2017 Q2	$8.36M	Buy	236,240 +78,770	+50%	+$2.43M	0.01%	985
2017 Q1	$3.72M	Sell	157,470 -9,000	-5%	-$178K	﹤0.01%	1370
2016 Q4	$2.22M	Hold	166,470	–	–	﹤0.01%	1756
2016 Q3	$3.09M	Buy	166,470 +7,900	+5%	+$139K	﹤0.01%	1447
2016 Q2	$1.94M	Hold	158,570	–	–	﹤0.01%	1741
2016 Q1	$1.07M	Hold	158,570	–	–	﹤0.01%	2052
2015 Q4	$1.46M	Hold	158,570	–	–	﹤0.01%	1862
2015 Q3	$2.85M	Sell	158,570 -4,730	-3%	-$109K	﹤0.01%	1382
2015 Q2	$4.86M	Buy	163,300 +5,400	+3%	+$136K	﹤0.01%	1131
2015 Q1	$3.48M	Buy	157,900 +2,200	+1%	+$55.8K	﹤0.01%	1336
2014 Q4	$4.27M	Sell	155,700 -3,500	-2%	-$85.2K	﹤0.01%	1201
2014 Q3	$3.08M	Hold	159,200	–	–	﹤0.01%	1404
2014 Q2	$2.71M	Buy	159,200 +50,100	+46%	+$690K	﹤0.01%	1551
2014 Q1	$1.55M	Sell	109,100 -1	-0%	-$14	﹤0.01%	1890
2013 Q4	$1.27M	Sell	109,101 -16,732	-13%	-$192K	﹤0.01%	2011
2013 Q3	$1.49M	Sell	125,833 -96,342	-43%	-$1.24M	﹤0.01%	1892
2013 Q2	$3.09M	Buy	+222,175	New	+$2.41M	﹤0.01%	1307

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

AllianceBernstein's EXAS Position: Q1 2026 in Review

AllianceBernstein sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 823,039 shares — an estimated $83.6M sold.

AllianceBernstein first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $180M in Q3 2018. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

AllianceBernstein reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
AllianceBernstein sold 823,039 Exact Sciences shares in Q1 2026, an estimated $83.6M.
AllianceBernstein first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
AllianceBernstein's Exact Sciences position peaked at $180M in Q3 2018.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.